Skip to main content
. 2022 Jan 29;2022:9997212. doi: 10.1155/2022/9997212

Figure 3.

Figure 3

Survival curve for breast cancer patients with respect to high and low expression: (a) ANRIL expression, (b) TUG1 expression, and (c) HIT expression.